Blurbs

Robert W. Baird Remains a Hold on Medpace Holdings (MEDP)

In a report issued on July 7, Eric Coldwell from Robert W. Baird maintained a Hold rating on Medpace Holdings (MEDPResearch Report), with a price target of $133.00. The company’s shares closed last Wednesday at $148.67.

According to TipRanks.com, Coldwell is a 5-star analyst with an average return of 7.7% and a 50.0% success rate. Coldwell covers the Healthcare sector, focusing on stocks such as Quest Diagnostics, AmerisourceBergen, and Cardinal Health.

Currently, the analyst consensus on Medpace Holdings is a Hold with an average price target of $139.00.

See the top stocks recommended by analysts >>

The company has a one-year high of $231.00 and a one-year low of $126.95. Currently, Medpace Holdings has an average volume of 335.2K.

Based on the recent corporate insider activity of 67 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of MEDP in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.

Read More on MEDP:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos
Videos

Latest News Feed